Genmab A/S Adjustments For Depreciation And Amortisation Expense
Genmab A/S (GMAB) reported Adjustments For Depreciation And Amortisation Expense of DKK 295.00 million for the 12-month period ending 2023-12-31, per its 6-K filed 2024-02-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2024-02-14
| Period end | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|
| 2023-12-31 | 295.00M DKK 6-K · filed 2024-02-14 |
| 2022-12-31 | 362.00M DKK 6-K · filed 2024-02-14 |
| 2021-12-31 | 248.00M DKK 6-K · filed 2024-02-14 |
| 2020-12-31 | 259.00M DKK 6-K · filed 2023-02-22 |
| 2019-12-31 | 139.00M DKK 6-K · filed 2022-02-16 |
| 2018-12-31 | 88.00M DKK 6-K · filed 2021-02-23 |
| 2017-12-31 | 70.00M DKK 20-F · filed 2020-03-30 |